Stage FocusSeed, Series A, Series B+
GeographyUK, Europe
TypeVC
Last Activity2026
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
LifeArc Ventures is part of LifeArc, a medical research charity with a remarkable funding model — it's self-financing through royalties from Keytruda (sold to CPPIB for $1.297B in 2019), giving it a substantial permanent capital base. The strategy is to invest £1.3B by 2030, and the portfolio has expanded from 14 companies in 2022 to 20 by end-2025, investing across therapeutics, HealthTech, and m...
Notable Investments
M
Maxion TherapeuticsT
Tribune TherapeuticsR
RQ BiotechnologyC
Closed Loop MedicineSimilar Funds
Syncona
London, United Kingdom
DeepTech NativeBiotechMedTechPre-SeedSeed
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedTechSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantum ComputingSemiconductorsSeedSeries A
HealthCap
Stockholm, Sweden
DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A